Solutions...

Pricing & Access
Strategies

Optimal pricing strategies for development decisions and market access.

Read more

Conjoint
Research

Delivering conjoint that can handle the intricacies of the pharma market.

Read more

Forecasting
Software

Allowing leading pharma companies to build evidence-based forecasts fast and easily.

Read more

Launch Sequence
Simulators

Get your country launch sequence right. Capture full value in the face of international reference pricing.

Read more

Training
Courses

Industry-leading pricing-for-market-access and forecasting training.

Read more

Conjoint studies frequently assume that product profile is the dominant driver of market share. However, product profile is often not the dominant driver and rarely is it the sole driver of market share. Other factors affect market share too, and you need to combine them with the output from your conjoint.

In this final paper in the “Making conjoint fit for pharma” series, we walk you through five evidence-based steps to make your conjoint market shares even more accurate and forecast-model ready.